You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Disease Modeling
In Vitro, In Vivo and Ex Vivo and ADME Assays
The evaluation of compounds in vivo is complemented by in vitro, in vivo and ex vivo assays, which provide further insight into a therapeutic's mechanism of action and effective concentration. These assays can also help identify and characterize pharmacodynamics and predictive biomarkers to enhance safety and efficacy and provide a more comprehensive data package for internal stakeholders, clinical partners, investors and regulatory agencies. GD3 has lab space, equipment and expertise, and we can discuss and execute these studies for you, providing comprehensive reports to guide your drug development programs.
Learn more about